Interventional Oncology Devices – Market Insights – Asia Pacific (Supplemental)

Despite the short term challenges posed by the COVID-19 pandemic, the Asia Pacific interventional oncology device market will see strong growth through 2031 driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of new competitors. However, a lack of reimbursement and pricing pressures will continue to remain a challenge.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in the Asia Pacific region from 2019 to 2031.

Table of contents